I

ITM Isotopen Technologien München AG

124 employees

Isotopen Technologien München is a holding company that owns biotechnology and radiopharmaceutical companies.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Pharmaceutical
Driving force to establish global standards regarding safety and efficacy of radiopharmaceuticals
Theranostic radioisotope platform technologies
Strategic alliances in order to further develop Theranostics
Biopharma
Medical Device
Global network to guarantee security of supply

Date founded

2004

Funding rounds raised

Total raised

$273M

from 10 investors over 10 rounds

I

ITM Isotopen Technologien München AG raised $273M on June 5, 2023

Investors: Carbyne Equity Partners, Nextech Invest, Qatar Investment Authority and Temasek

I

ITM Isotopen Technologien München AG raised $36M on March 22, 2022

Investors: PORTLAND HOLDINGS LIMITED

I

ITM Isotopen Technologien München AG raised $28M on February 16, 2022

Investors: Grand Pharmaceutical (China) Co., Ltd.

I

ITM Isotopen Technologien München AG raised $30M on June 10, 2021

Investors: FRIBA Investment and PORTLAND HOLDINGS LIMITED

I

ITM Isotopen Technologien München AG raised $108M on April 22, 2021

Investors: -

I

ITM Isotopen Technologien München AG raised $44M on February 11, 2020

Investors: European Investment Bank

FAQ